Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Chiyuki Okuda"'
Autor:
Shiro Fujita, Katsuhiro Masago, Jumpei Takeshita, Chiyuki Okuda, Kyoko Otsuka, Akito Hata, Reiko Kaji, Nobuyuki Katakami, Yukio Hirata
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130219 (2015)
Treatment for patients with advanced non-small cell lung cancer (NSCLC) is often determined by the presence of biomarkers that predict the response to agents targeting specific molecular pathways. Demands for multiplex analysis of the genes involved
Externí odkaz:
https://doaj.org/article/3baaf1bf0f034f4e8ffc7ca98d0b083b
Autor:
Shoji Fukushima, Nobuyuki Katakami, Akira Okada, Keizo Fukushima, Chiyuki Okuda, Kei Irie, Reiko Kaji, Akito Hata, Nobuyuki Sugioka, Yutaka Okada, Yoshio Masuda
Publikováno v:
Journal of Oncology Pharmacy Practice. 25:865-868
Background Irinotecan (CPT-11) is the key drug used in chemotherapy for many malignant tumors. CPT-11 has cholinergic activity and induces perspiration during intravenous administration. In this study, concentrations of CPT-11 and its active metaboli
Autor:
Katsuhiro Masago, Chiyuki Okuda, Reiko Kaji, Yuko Yoshizumi, Akito Hata, Yasushi Yatabe, Shiro Fujita, Nobuyuki Katakami, Yukio Hirata
Publikováno v:
Pathology International. 68:167-173
The aim of this study was to compare the accuracy of the QuantStudio 3D Digital polymerase chain reaction (dPCR) system and a PCR-based next generation sequencing (NGS) system for detecting a secondary mutation in the epidermal growth factor receptor
Autor:
Hiroshi Yoshida, Shigeki Nanjo, Yukio Hirata, Yukihiro Imai, Shiro Fujita, Nobuyuki Katakami, Kota Zama, Akito Hata, Katsuhiro Masago, Reiko Kaji, Chiyuki Okuda
Publikováno v:
Oncotarget
// Akito Hata 1 , Nobuyuki Katakami 1 , Shigeki Nanjo 1 , Chiyuki Okuda 1 , Reiko Kaji 1 , Katsuhiro Masago 1 , Shiro Fujita 1 , Hiroshi Yoshida 2 , Kota Zama 2 , Yukihiro Imai 3 and Yukio Hirata 1 1 Division of Integrated Oncology, Institute of Biom
Autor:
Katsuhiro Masago, Nobuyuki Katakami, Chiyuki Okuda, Akito Hata, Reiko Kaji, Yukio Hirata, Shiro Fujita
Publikováno v:
Biomedical Reports
Errors in sequencing are a major obstacle in the interpretation of next-generation sequencing (NGS) results. In the present study, sequencing errors identified from analysis of single nucleotide variants (SNVs) identified during exome sequencing of h
Autor:
Reiko Kaji, Akito Hata, Shiro Fujita, Chiyuki Okuda, Nobuyuki Katakami, Katsuhiro Masago, Yukio Hirata
Publikováno v:
Anticancer Research. 37:2269-2274
Aim The aim of this study was to evaluate whether irradiation induces the expression of tumor programed cell death ligand 1 (PD-L1) in patients with non-small cell lung cancer (NSCLC). Patients and methods Seventeen patients with NSCLC who received c
Autor:
Katsuhiro, Masago, Shiro, Fujita, Akito, Hata, Chiyuki, Okuda, Yuko, Yoshizumi, Reiko, Kaji, Nobuyuki, Katakami, Yukio, Hirata, Yasushi, Yatabe
Publikováno v:
Pathology international. 68(3)
The aim of this study was to compare the accuracy of the QuantStudio 3D Digital polymerase chain reaction (dPCR) system and a PCR-based next generation sequencing (NGS) system for detecting a secondary mutation in the epidermal growth factor receptor
Autor:
Daisuke Tamura, Hideaki Okada, Kei Irie, Shigeki Nanjo, Akito Hata, Nobuyuki Katakami, Reiko Kaji, Shoji Fukushima, Chiyuki Okuda, Hiroshi Okada
Publikováno v:
British Journal of Cancer
Background: Osimertinib demonstrated promising efficacy for refractory leptomeningeal metastases (LM) in preclinical data and a clinical study at 160 mg, but there is limited data for the standard 80 mg dose. Methods: T790M-positive patients with sus
Autor:
Katsuhiro Masago, Shigeki Nanjo, Chiyuki Okuda, Nobuyuki Katakami, Yukihiro Imai, Reiko Kaji, Akito Hata, Yukio Hirata, Kota Zama, Shiro Fujita, Hiroshi Yoshida
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 111
Background Differential biology and prognosis between T790M+ and T790M- populations imply immunological differences also. Methods We retrospectively analyzed programmed death-ligand 1 (PD-L1) expression and T790M status in rebiopsied samples of epide
Publikováno v:
In vivo (Athens, Greece). 31(3)
Aim The aim of the present study was to compare successful rate, failure reasons, and complications among procedures of histological rebiopsy. Patients and methods We retrospectively reviewed medical records of histologically rebiopsied cases with no